According to A Latest intelligence report published by Market IntelliX, the global market for Vaccine (Include COVID-19) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Inactivated Vaccine segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Public has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Vaccine (Include COVID-19) include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

This report aims to provide a comprehensive study of the global market for Vaccine (Include COVID-19). Report Highlights:

(1) Global Vaccine (Include COVID-19) market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Vaccine (Include COVID-19) market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Vaccine (Include COVID-19) market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Vaccine (Include COVID-19) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Vaccine (Include COVID-19) segment by type and by application and regional segment by type and by application.

(6) Vaccine (Include COVID-19) industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Inactivated Vaccine

Attenuated Vaccine

mRNA

Other

Market segment by application, can be divided into

Public

Private

Market segment by players, this report covers

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

KM Biologics

Pfizer

Merck

Sinovac

Zhejiang Pukang

Walvax Biotechnology

Bharat Biotech

Serum Institute

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

LG Life Sciences

1 Market Overview

1.1 Product Overview and Scope of Vaccine (Include COVID-19)

1.2 Global Vaccine (Include COVID-19) Market Size and Forecast

1.3 China Vaccine (Include COVID-19) Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Vaccine (Include COVID-19) Share in Global Market, 2018-2029

1.4.2 Vaccine (Include COVID-19) Market Size: China VS Global, 2018-2029

1.5 Vaccine (Include COVID-19) Market Dynamics

1.5.1 Vaccine (Include COVID-19) Market Drivers

1.5.2 Vaccine (Include COVID-19) Market Restraints

1.5.3 Vaccine (Include COVID-19) Industry Trends

1.5.4 Vaccine (Include COVID-19) Industry Policy

2 Global Competitive Situation by Company

2.1 Global Vaccine (Include COVID-19) Revenue by Company (2018-2023)

2.2 Global Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Vaccine (Include COVID-19) Concentration Ratio

2.4 Global Vaccine (Include COVID-19) Mergers & Acquisitions, Expansion Plans

2.5 Global Vaccine (Include COVID-19) Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Vaccine (Include COVID-19) Revenue by Company (2018-2023)

3.2 China Vaccine (Include COVID-19) Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Vaccine (Include COVID-19), Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Vaccine (Include COVID-19) Industry Chain

4.2 Vaccine (Include COVID-19) Upstream Analysis

4.3 Vaccine (Include COVID-19) Midstream Analysis

4.4 Vaccine (Include COVID-19) Downstream Analysis

5 Sights by Type

5.1 Vaccine (Include COVID-19) Classification

5.1.1 Inactivated Vaccine

5.1.2 Attenuated Vaccine

5.1.3 mRNA

5.1.4 Other

5.2 By Type, Global Vaccine (Include COVID-19) Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Vaccine (Include COVID-19) Revenue, 2018-2029

6 Sights by Application

6.1 Vaccine (Include COVID-19) Segment by Application

6.1.1 Public

6.1.2 Private

6.2 By Application, Global Vaccine (Include COVID-19) Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Vaccine (Include COVID-19) Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Vaccine (Include COVID-19) Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Vaccine (Include COVID-19) Market Size, 2018-2029

7.3 North America

7.3.1 North America Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Vaccine (Include COVID-19) Market Size Market Share

7.4 Europe

7.4.1 Europe Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Vaccine (Include COVID-19) Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Vaccine (Include COVID-19) Market Size Market Share

7.6 South America

7.6.1 South America Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Vaccine (Include COVID-19) Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Vaccine (Include COVID-19) Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Vaccine (Include COVID-19) Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Vaccine (Include COVID-19) Market Size, 2018-2029

8.3.2 By Company, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Vaccine (Include COVID-19) Market Size, 2018-2029

8.4.2 By Company, Europe Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Vaccine (Include COVID-19) Market Size, 2018-2029

8.5.2 By Company, China Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.5.3 By Type, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Vaccine (Include COVID-19) Market Size, 2018-2029

8.6.2 By Company, Japan Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Vaccine (Include COVID-19) Market Size, 2018-2029

8.7.2 By Company, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Vaccine (Include COVID-19) Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Vaccine (Include COVID-19) Market Size, 2018-2029

8.9.2 By Company, India Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.9.3 By Type, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Vaccine (Include COVID-19) Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Sanofi

9.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.1.2 Sanofi Company Profile and Main Business

9.1.3 Sanofi Vaccine (Include COVID-19) Models, Specifications and Application

9.1.4 Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.1.5 Sanofi Recent Developments

9.2 CSL

9.2.1 CSL Company Information, Head Office, Market Area and Industry Position

9.2.2 CSL Company Profile and Main Business

9.2.3 CSL Vaccine (Include COVID-19) Models, Specifications and Application

9.2.4 CSL Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.2.5 CSL Recent Developments

9.3 GSK

9.3.1 GSK Company Information, Head Office, Market Area and Industry Position

9.3.2 GSK Company Profile and Main Business

9.3.3 GSK Vaccine (Include COVID-19) Models, Specifications and Application

9.3.4 GSK Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.3.5 GSK Recent Developments

9.4 Viatris

9.4.1 Viatris Company Information, Head Office, Market Area and Industry Position

9.4.2 Viatris Company Profile and Main Business

9.4.3 Viatris Vaccine (Include COVID-19) Models, Specifications and Application

9.4.4 Viatris Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.4.5 Viatris Recent Developments

9.5 AstraZeneca

9.5.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.5.2 AstraZeneca Company Profile and Main Business

9.5.3 AstraZeneca Vaccine (Include COVID-19) Models, Specifications and Application

9.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.5.5 AstraZeneca Recent Developments

9.6 Hualan Bio

9.6.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position

9.6.2 Hualan Bio Company Profile and Main Business

9.6.3 Hualan Bio Vaccine (Include COVID-19) Models, Specifications and Application

9.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.6.5 Hualan Bio Recent Developments

9.7 Changchun Institute of Biological

9.7.1 Changchun Institute of Biological Company Information, Head Office, Market Area and Industry Position

9.7.2 Changchun Institute of Biological Company Profile and Main Business

9.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Models, Specifications and Application

9.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.7.5 Changchun Institute of Biological Recent Developments

9.8 Sinovac

9.8.1 Sinovac Company Information, Head Office, Market Area and Industry Position

9.8.2 Sinovac Company Profile and Main Business

9.8.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

9.8.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.8.5 Sinovac Recent Developments

9.9 KM Biologics

9.9.1 KM Biologics Company Information, Head Office, Market Area and Industry Position

9.9.2 KM Biologics Company Profile and Main Business

9.9.3 KM Biologics Vaccine (Include COVID-19) Models, Specifications and Application

9.9.4 KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.9.5 KM Biologics Recent Developments

9.10 Pfizer

9.10.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.10.2 Pfizer Company Profile and Main Business

9.10.3 Pfizer Vaccine (Include COVID-19) Models, Specifications and Application

9.10.4 Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.10.5 Pfizer Recent Developments

9.11 Merck

9.11.1 Merck Company Information, Head Office, Market Area and Industry Position

9.11.2 Merck Company Profile and Main Business

9.11.3 Merck Vaccine (Include COVID-19) Models, Specifications and Application

9.11.4 Merck Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.11.5 Merck Recent Developments

9.12 Sinovac

9.12.1 Sinovac Company Information, Head Office, Market Area and Industry Position

9.12.2 Sinovac Company Profile and Main Business

9.12.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

9.12.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.12.5 Sinovac Recent Developments

9.13 Zhejiang Pukang

9.13.1 Zhejiang Pukang Company Information, Head Office, Market Area and Industry Position

9.13.2 Zhejiang Pukang Company Profile and Main Business

9.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Models, Specifications and Application

9.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.13.5 Zhejiang Pukang Recent Developments

9.14 Walvax Biotechnology

9.14.1 Walvax Biotechnology Company Information, Head Office, Market Area and Industry Position

9.14.2 Walvax Biotechnology Company Profile and Main Business

9.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Models, Specifications and Application

9.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.14.5 Walvax Biotechnology Recent Developments

9.15 Bharat Biotech

9.15.1 Bharat Biotech Company Information, Head Office, Market Area and Industry Position

9.15.2 Bharat Biotech Company Profile and Main Business

9.15.3 Bharat Biotech Vaccine (Include COVID-19) Models, Specifications and Application

9.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.15.5 Bharat Biotech Recent Developments

9.16 Serum Institute

9.16.1 Serum Institute Company Information, Head Office, Market Area and Industry Position

9.16.2 Serum Institute Company Profile and Main Business

9.16.3 Serum Institute Vaccine (Include COVID-19) Models, Specifications and Application

9.16.4 Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.16.5 Serum Institute Recent Developments

9.17 Panacea Biotec Ltd

9.17.1 Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

9.17.2 Panacea Biotec Ltd Company Profile and Main Business

9.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Models, Specifications and Application

9.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.17.5 Panacea Biotec Ltd Recent Developments

9.18 Bio-Med

9.18.1 Bio-Med Company Information, Head Office, Market Area and Industry Position

9.18.2 Bio-Med Company Profile and Main Business

9.18.3 Bio-Med Vaccine (Include COVID-19) Models, Specifications and Application

9.18.4 Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.18.5 Bio-Med Recent Developments

9.19 Halfkin Bio-Pharmaceuticals

9.19.1 Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.19.2 Halfkin Bio-Pharmaceuticals Company Profile and Main Business

9.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Models, Specifications and Application

9.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.19.5 Halfkin Bio-Pharmaceuticals Recent Developments

9.20 LG Life Sciences

9.20.1 LG Life Sciences Company Information, Head Office, Market Area and Industry Position

9.20.2 LG Life Sciences Company Profile and Main Business

9.20.3 LG Life Sciences Vaccine (Include COVID-19) Models, Specifications and Application

9.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

9.20.5 LG Life Sciences Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Vaccine (Include COVID-19) Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Vaccine (Include COVID-19) Market Restraints

Table 3. Vaccine (Include COVID-19) Market Trends

Table 4. Vaccine (Include COVID-19) Industry Policy

Table 5. Global Vaccine (Include COVID-19) Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Vaccine (Include COVID-19) Revenue Market Share by Company (2018-2023)

Table 7. Global Vaccine (Include COVID-19) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Vaccine (Include COVID-19) Mergers & Acquisitions, Expansion Plans

Table 9. Global Vaccine (Include COVID-19) Manufacturers Product Type

Table 10. China Vaccine (Include COVID-19) Revenue by Company (2018-2023) & (US$ million)

Table 11. China Vaccine (Include COVID-19) Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Vaccine (Include COVID-19) Upstream (Raw Materials)

Table 13. Global Vaccine (Include COVID-19) Typical Customers

Table 14. Vaccine (Include COVID-19) Typical Distributors

Table 15. By Type, Global Vaccine (Include COVID-19) Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Vaccine (Include COVID-19) Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Vaccine (Include COVID-19) Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Vaccine (Include COVID-19) Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Vaccine (Include COVID-19) Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Vaccine (Include COVID-19) Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Vaccine (Include COVID-19) Revenue Market Share, 2018-2029

Table 22. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 23. Sanofi Company Profile and Main Business

Table 24. Sanofi Vaccine (Include COVID-19) Models, Specifications and Application

Table 25. Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 26. Sanofi Recent Developments

Table 27. CSL Company Information, Head Office, Market Area and Industry Position

Table 28. CSL Company Profile and Main Business

Table 29. CSL Vaccine (Include COVID-19) Models, Specifications and Application

Table 30. CSL Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 31. CSL Recent Developments

Table 32. GSK Company Information, Head Office, Market Area and Industry Position

Table 33. GSK Company Profile and Main Business

Table 34. GSK Vaccine (Include COVID-19) Models, Specifications and Application

Table 35. GSK Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 36. GSK Recent Developments

Table 37. Viatris Company Information, Head Office, Market Area and Industry Position

Table 38. Viatris Company Profile and Main Business

Table 39. Viatris Vaccine (Include COVID-19) Models, Specifications and Application

Table 40. Viatris Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 41. Viatris Recent Developments

Table 42. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 43. AstraZeneca Company Profile and Main Business

Table 44. AstraZeneca Vaccine (Include COVID-19) Models, Specifications and Application

Table 45. AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 46. AstraZeneca Recent Developments

Table 47. Hualan Bio Company Information, Head Office, Market Area and Industry Position

Table 48. Hualan Bio Company Profile and Main Business

Table 49. Hualan Bio Vaccine (Include COVID-19) Models, Specifications and Application

Table 50. Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 51. Hualan Bio Recent Developments

Table 52. Changchun Institute of Biological Company Information, Head Office, Market Area and Industry Position

Table 53. Changchun Institute of Biological Company Profile and Main Business

Table 54. Changchun Institute of Biological Vaccine (Include COVID-19) Models, Specifications and Application

Table 55. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 56. Changchun Institute of Biological Recent Developments

Table 57. Sinovac Company Information, Head Office, Market Area and Industry Position

Table 58. Sinovac Company Profile and Main Business

Table 59. Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

Table 60. Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 61. Sinovac Recent Developments

Table 62. KM Biologics Company Information, Head Office, Market Area and Industry Position

Table 63. KM Biologics Company Profile and Main Business

Table 64. KM Biologics Vaccine (Include COVID-19) Models, Specifications and Application

Table 65. KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 66. KM Biologics Recent Developments

Table 67. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 68. Pfizer Company Profile and Main Business

Table 69. Pfizer Vaccine (Include COVID-19) Models, Specifications and Application

Table 70. Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 71. Pfizer Recent Developments

Table 72. Merck Company Information, Head Office, Market Area and Industry Position

Table 73. Merck Company Profile and Main Business

Table 74. Merck Vaccine (Include COVID-19) Models, Specifications and Application

Table 75. Merck Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 76. Merck Recent Developments

Table 77. Sinovac Company Information, Head Office, Market Area and Industry Position

Table 78. Sinovac Company Profile and Main Business

Table 79. Sinovac Vaccine (Include COVID-19) Models, Specifications and Application

Table 80. Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 81. Sinovac Recent Developments

Table 82. Zhejiang Pukang Company Information, Head Office, Market Area and Industry Position

Table 83. Zhejiang Pukang Company Profile and Main Business

Table 84. Zhejiang Pukang Vaccine (Include COVID-19) Models, Specifications and Application

Table 85. Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 86. Zhejiang Pukang Recent Developments

Table 87. Walvax Biotechnology Company Information, Head Office, Market Area and Industry Position

Table 88. Walvax Biotechnology Company Profile and Main Business

Table 89. Walvax Biotechnology Vaccine (Include COVID-19) Models, Specifications and Application

Table 90. Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 91. Walvax Biotechnology Recent Developments

Table 92. Bharat Biotech Company Information, Head Office, Market Area and Industry Position

Table 93. Bharat Biotech Company Profile and Main Business

Table 94. Bharat Biotech Vaccine (Include COVID-19) Models, Specifications and Application

Table 95. Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 96. Bharat Biotech Recent Developments

Table 97. Serum Institute Company Information, Head Office, Market Area and Industry Position

Table 98. Serum Institute Company Profile and Main Business

Table 99. Serum Institute Vaccine (Include COVID-19) Models, Specifications and Application

Table 100. Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 101. Serum Institute Recent Developments

Table 102. Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

Table 103. Panacea Biotec Ltd Company Profile and Main Business

Table 104. Panacea Biotec Ltd Vaccine (Include COVID-19) Models, Specifications and Application

Table 105. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 106. Panacea Biotec Ltd Recent Developments

Table 107. Bio-Med Company Information, Head Office, Market Area and Industry Position

Table 108. Bio-Med Company Profile and Main Business

Table 109. Bio-Med Vaccine (Include COVID-19) Models, Specifications and Application

Table 110. Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 111. Bio-Med Recent Developments

Table 112. Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 113. Halfkin Bio-Pharmaceuticals Company Profile and Main Business

Table 114. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Models, Specifications and Application

Table 115. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 116. Halfkin Bio-Pharmaceuticals Recent Developments

Table 117. LG Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 118. LG Life Sciences Company Profile and Main Business

Table 119. LG Life Sciences Vaccine (Include COVID-19) Models, Specifications and Application

Table 120. LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023

Table 121. LG Life Sciences Recent Developments

List of Figure

Figure 1. Vaccine (Include COVID-19) Picture

Figure 2. Global Vaccine (Include COVID-19) Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Vaccine (Include COVID-19) Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Vaccine (Include COVID-19) Market Share of Global

Figure 5. Global Vaccine (Include COVID-19) Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Vaccine (Include COVID-19) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Vaccine (Include COVID-19) Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Vaccine (Include COVID-19) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Vaccine (Include COVID-19) Industry Chain

Figure 10. Inactivated Vaccine

Figure 11. Attenuated Vaccine

Figure 12. mRNA

Figure 13. Other

Figure 14. By Type, Global Vaccine (Include COVID-19) Revenue, 2018-2029, US$ Million

Figure 15. By Type, Global Vaccine (Include COVID-19) Revenue Market Share, 2018-2029

Figure 16. Public

Figure 17. Private

Figure 18. By Application, Global Vaccine (Include COVID-19) Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Vaccine (Include COVID-19) Revenue Market Share, 2018-2029

Figure 20. By Region, Global Vaccine (Include COVID-19) Revenue Market Share, 2018-2029

Figure 21. North America Vaccine (Include COVID-19) Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

Figure 23. Europe Vaccine (Include COVID-19) Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Vaccine (Include COVID-19) Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

Figure 27. South America Vaccine (Include COVID-19) Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Vaccine (Include COVID-19) Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Vaccine (Include COVID-19) Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 32. By Type, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 34. Europe Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 36. By Type, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 38. China Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 40. By Type, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 42. Japan Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 44. By Type, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 48. By Type, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 54. India Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 56. By Type, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Vaccine (Include COVID-19) Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Vaccine (Include COVID-19) Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Vaccine (Include COVID-19) Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)